Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
14,476,121
-
Shares change
-
+1,855,826
-
Total reported value, excl. options
-
$104,126,600
-
Value change
-
+$13,345,733
-
Put/Call ratio
-
104%
-
Number of buys
-
31
-
Number of sells
-
11
-
Price
-
$7.20
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2014
As of 31 Mar 2014 SINOVAC BIOTECH LTD. - Common Shares (SVA) had 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,476,121 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT CO LLP, ORBIMED ADVISORS LLC, DAVIS SELECTED ADVISERS, FIL Ltd, RENAISSANCE TECHNOLOGIES LLC, Visium Asset Management, LP, BlackRock Fund Advisors, PICTET ASSET MANAGEMENT LTD, JANE STREET GROUP, LLC, and BOGLE INVESTMENT MANAGEMENT L P /DE/.
This table shows 51 institutional shareholders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.